We are unlocking a missing dimension in CKD assessment 

Chronic Kidney Disease (CKD) affects millions worldwide, yet current diagnostics focus on filtration (GFR, albuminuria) and overlook tubular function, leaving a critical gap in risk stratification and treatment guidance. Equilibrium Diagnostic addresses this unmet need with the AP Index, a non-invasive measure of tubular function based on urinary ammonium and pH. The AP Index enables early detection of acid retention, predicts CKD progression, and supports personalized treatment decisions. Integrated easily into clinical workflows, the platform can slow CKD progression, reduce dialysis needs, lower healthcare costs, and has applications beyond CKD.